258 related articles for article (PubMed ID: 19370579)
1. Treatment for amphetamine withdrawal.
Shoptaw SJ; Kao U; Heinzerling K; Ling W
Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003021. PubMed ID: 19370579
[TBL] [Abstract][Full Text] [Related]
2. Treatment for amphetamine withdrawal.
Srisurapanont M; Jarusuraisin N; Kittirattanapaiboon P
Cochrane Database Syst Rev; 2001; (4):CD003021. PubMed ID: 11687170
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment.
Srisurapanont M; Jarusuraisin N; Jittiwutikan J
Aust N Z J Psychiatry; 1999 Feb; 33(1):94-8. PubMed ID: 10197891
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine for fibromyalgia in adults.
Welsch P; Bernardy K; Derry S; Moore RA; Häuser W
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012708. PubMed ID: 30080242
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials.
Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ
Drug Alcohol Rev; 2023 Jan; 42(1):7-19. PubMed ID: 35862266
[TBL] [Abstract][Full Text] [Related]
7. Amineptine in the treatment of amphetamine withdrawal: a placebo-controlled, randomised, double-blind study.
Jittiwutikan J; Srisurapanont M; Jarusuraisin N
J Med Assoc Thai; 1997 Sep; 80(9):587-92. PubMed ID: 9347672
[TBL] [Abstract][Full Text] [Related]
8. Treatment for amphetamine dependence and abuse.
Srisurapanont M; Jarusuraisin N; Kittirattanapaiboon P
Cochrane Database Syst Rev; 2001; (4):CD003022. PubMed ID: 11687171
[TBL] [Abstract][Full Text] [Related]
9. Treatment for amphetamine psychosis.
Shoptaw SJ; Kao U; Ling W
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003026. PubMed ID: 19160215
[TBL] [Abstract][Full Text] [Related]
10. Treatment for amphetamine psychosis.
Shoptaw SJ; Kao U; Ling WW
Cochrane Database Syst Rev; 2008 Oct; (4):CD003026. PubMed ID: 18843639
[TBL] [Abstract][Full Text] [Related]
11. Opioid antagonists for alcohol dependence.
Srisurapanont M; Jarusuraisin N
Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J; Castells X; Ehimare UP; Smith CH
Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
[TBL] [Abstract][Full Text] [Related]
15. Alpha2-adrenergic agonists for the management of opioid withdrawal.
Gowing L; Farrell MF; Ali R; White JM
Cochrane Database Syst Rev; 2014 Mar; (3):CD002024. PubMed ID: 24683051
[TBL] [Abstract][Full Text] [Related]
16. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
17. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
[TBL] [Abstract][Full Text] [Related]
18. Baclofen for alcohol withdrawal.
Liu J; Wang LN
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31689723
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
[TBL] [Abstract][Full Text] [Related]
20. Modafinil for people with schizophrenia or related disorders.
Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
